Literature DB >> 22179598

Assessment of "non-recordable" electroretinograms by 9 Hz flicker stimulation under scotopic conditions.

Andreas Schatz1, Robert Wilke, Torsten Strasser, Florian Gekeler, Andre Messias, Eberhart Zrenner.   

Abstract

To refine methods of electroretinographical (ERG) recording for the analysis of low retinal potentials under scotopic conditions in advanced retinal degenerative diseases. Standard Ganzfeld ERG equipment (Diagnosys LLC, Cambridge, UK) was used in 27 healthy volunteers (mean age 28 ± SD 8.5 years) to define the stimulation protocol. The protocol was then applied in clinical routine and 992 recordings were obtained from patients (mean age 40.6 ± 18.3 years) over a period of 5 years. A blue stimulus with a flicker frequency of 9 Hz was specified under scotopic conditions to preferentially record rod-driven responses. A range of stimulus strengths (0.0000012-6.32 scot. cd s/m² and 6-14 ms flash duration) was tested for maximal amplitudes and interference between rods and cones. Analysis of results was done by standard Fourier Transformation and assessment of signal-to-noise ratio. Optimized stimulus parameters were found to be a time-integrated luminance of 0.012 scot. cd s/m² using a blue (470 nm) flash of 10 ms duration at a repetition frequency of 9 Hz. Characteristic stimulus strength versus amplitude curves and tests with stimuli of red or green wavelength suggest a predominant rod-system response. The 9 Hz response was found statistically distinguishable from noise in 38% of patients with otherwise non-recordable rod responses according to International Society for Clinical Electrophysiology of Vision standards. Thus, we believe this protocol can be used to record ERG potentials in patients with advanced retinal diseases and in the evaluation of potential treatments for these patients. The ease of implementation in clinical routine and of statistical evaluation providing an observer-independent evaluation may further facilitate its employment.

Entities:  

Mesh:

Year:  2011        PMID: 22179598     DOI: 10.1007/s10633-011-9302-1

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  37 in total

1.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

2.  Cone electroretinography by flicker.

Authors:  E DODT
Journal:  Nature       Date:  1951-10-27       Impact factor: 49.962

3.  Origin of negative potentials in the light-adapted ERG of cat retina.

Authors:  L J Frishman; R H Steinberg
Journal:  J Neurophysiol       Date:  1990-06       Impact factor: 2.714

4.  Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.

Authors:  Eliot L Berson; Bernard Rosner; Michael A Sandberg; Carol Weigel-DiFranco; Robert J Brockhurst; K C Hayes; Elizabeth J Johnson; Ellen J Anderson; Chris A Johnson; Alexander R Gaudio; Walter C Willett; Ernst J Schaefer
Journal:  Arch Ophthalmol       Date:  2010-04

5.  Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa.

Authors:  S O Andréasson; M A Sandberg; E L Berson
Journal:  Am J Ophthalmol       Date:  1988-05-15       Impact factor: 5.258

6.  Cone and rod dysfunction in fundus albipunctatus with RDH5 mutation: an electrophysiological study.

Authors:  Yasuhiro Niwa; Mineo Kondo; Shinji Ueno; Makoto Nakamura; Hiroko Terasaki; Yozo Miyake
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

7.  The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma.

Authors:  S Viswanathan; L J Frishman; J G Robson; R S Harwerth; E L Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

8.  Single doses of all-trans-N-retinylacetamide slow down the ERG amplitude recovery after bleaching in rats.

Authors:  Andre Messias; Eberhart Zrenner; Radouil Tzekov; David McGee; Tobias Peters; Barbara Wilhelm; Aneta Baryluk; Ryo Kubota; Florian Gekeler
Journal:  Doc Ophthalmol       Date:  2009-12-11       Impact factor: 2.379

9.  Improved electrode for electroretinography.

Authors:  W W Dawson; G L Trick; C A Litzkow
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-09       Impact factor: 4.799

10.  Subretinal electronic chips allow blind patients to read letters and combine them to words.

Authors:  Eberhart Zrenner; Karl Ulrich Bartz-Schmidt; Heval Benav; Dorothea Besch; Anna Bruckmann; Veit-Peter Gabel; Florian Gekeler; Udo Greppmaier; Alex Harscher; Steffen Kibbel; Johannes Koch; Akos Kusnyerik; Tobias Peters; Katarina Stingl; Helmut Sachs; Alfred Stett; Peter Szurman; Barbara Wilhelm; Robert Wilke
Journal:  Proc Biol Sci       Date:  2010-11-03       Impact factor: 5.349

View more
  4 in total

1.  Harmonization of Outcomes and Vision Endpoints in Vision Restoration Trials: Recommendations from the International HOVER Taskforce.

Authors:  Lauren N Ayton; Joseph F Rizzo; Ian L Bailey; August Colenbrander; Gislin Dagnelie; Duane R Geruschat; Philip C Hessburg; Chris D McCarthy; Matthew A Petoe; Gary S Rubin; Philip R Troyk
Journal:  Transl Vis Sci Technol       Date:  2020-07-16       Impact factor: 3.283

2.  Human flicker electroretinography using different temporal modulations at mesopic and photopic luminance levels.

Authors:  Balázs Vince Nagy; Mirella Telles Salgueiro Barboni; Cristiane Maria Gomes Martins; Marcelo Fernandes da Costa; Jan Kremers; Dora Fix Ventura
Journal:  Doc Ophthalmol       Date:  2014-06-27       Impact factor: 2.379

3.  Electroretinographic assessment of retinal function during acute exposure to normobaric hypoxia.

Authors:  Andreas Schatz; Maurice Breithaupt; Jens Hudemann; Andreas Niess; André Messias; Eberhart Zrenner; Karl Ulrich Bartz-Schmidt; Florian Gekeler; Gabriel Willmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-06       Impact factor: 3.117

4.  Rod and cone function in patients with KCNV2 retinopathy.

Authors:  Ditta Zobor; Susanne Kohl; Bernd Wissinger; Eberhart Zrenner; Herbert Jägle
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.